skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I have 13 positions "growth" stocks portfolioat different weighting performing prity well accept for SQ & NFLX both 15% down.
Weighting:
CSU- 17.3%
LSPD- 10.8%
BYD.un- 3.7%
KL- 5.7%
KXS- 2.8%
AQN- 3.8%
ADBE- 8.6%
AMZN- 9.6%
SQ- 5.9%
NFLX- 5.6%
MA- 12.4%
MSFT- 7.8%
AYX- 6.6%
I have 40K kash to invest and Im thinking of buying new 5% possition of GSY and addinng 1.5% to BYD.UN or to KXS. What is your opinion and mayby different sugestion for new stock names and adding to different positions.
Thanks for excellent service.
Andrew
Read Answer Asked by Andrzej on December 11, 2019
Q: Goodafternoon 5i'
I am not concerned about the sector but wondered how you might rank these companies as buys currently and for the long term: NVDA, CRM, TEAM, MSFT, INTC, QCOM, GILD, DXCM
Thanks for the great work
Read Answer Asked by joseph on December 11, 2019
Q: I hold small positions of each in my US RSP account and all have been down and show no obvious signs of a recovery. Should I sell and switch to alternate stocks.
Thank you
Read Answer Asked by Russell on December 10, 2019
Q: Hello Peter and colleagues,
Is VEQT (100% equity) a growth ETF? (where can one find this information) Comparing VEQT with VGRO (80/20 equity/bond mix) can we say that VEQT has more potential for growth in long term (and more risk)? If Is VEQT is not a growth ETF is there a growth ETF that is 100% equity? Would you suggest any better alternative than both VEQT and VGRO?
Read Answer Asked by Hassan on December 10, 2019
Q: Good afternoon,
Looking to add US healthcare to my portfolio. I would appreciate your thoughts and ranking on the following US healthcare and service providers; MCK, BDX, SYK, UNH, HUM and MDT. I am open to other recommendations.
Thank you,
Patrick
Read Answer Asked by Patrick on December 09, 2019
Q: Kalvista flunked a drug trial and the stock was down 20% premarket. Now the stock is up 4%. Any idea why?
Read Answer Asked by hal on December 09, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!